Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102381990A details a cost-effective Ruthenium-catalyzed asymmetric hydrogenation route for N-benzyl phenylephrine intermediates, offering superior purity and supply chain reliability.
Patent CN102070468B reveals a high-yield route for Ractopamine. Reduced waste, >93% purity. Ideal for reliable pharmaceutical intermediate suppliers seeking cost efficiency.
Patent CN102408342B reveals a novel fluorene-based diamine synthesis offering enhanced solubility and photoelectric properties for high-performance polyimides.
Patent CN113461679B reveals a novel 5-step synthesis for benzazepine isatin intermediates, offering mild conditions and high purity for pharmaceutical applications.
Patent CN111943950A details a safer, one-pot synthesis for Relebactam intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel synthesis method for Buparvaquone intermediate ensures high purity and scalable production for global veterinary pharmaceutical supply chains reducing manufacturing complexity.
Patent CN111087315A reveals a novel aqueous hydrogenation route for Eltrombopag intermediate BPCA, offering superior purity and reduced manufacturing costs for pharmaceutical supply chains.
Novel Ru-catalyzed route for (S)-duloxetine intermediate offers high ee and yield without nitrogen protection, reducing manufacturing costs.
Novel chiral synthesis route for octahydro-2H-pyrrolo[3,4-c]pyridine derivatives offering high purity and scalable pharmaceutical intermediate production capabilities.
Novel Raney-Ni catalyzed hydrogenation reduces steps for 2 4 6 trifluorobenzylamine ensuring high purity and cost reduction in pharma intermediate manufacturing.
Patent CN115466255B reveals a high-yield Tropinol synthesis using K5PPdW11O39/C, offering safer alternatives to Raney Nickel for reliable pharmaceutical intermediates supply chains.
Patent CN114369044A introduces a continuous method using modified skeletal nickel, offering high purity reactive dye intermediates with reduced production costs.
Patent CN101759591A reveals a greener Agomelatine synthesis using cyclohexane and one-pot acetylation, offering significant cost reduction and high purity for API manufacturers.
Patent CN106008453B reveals green hydrogenation method. Reduces waste, ensures high purity, offers cost-effective supply chain solutions for pharma intermediates.
Patent CN112707836A reveals a high-yield 5-step route for Broflanilide. Eliminates deep cooling, improves scalability for agrochemical manufacturers.
Patent CN110655456B details Co-catalyzed hydrogenation of E/Z mixed olefins. Offers high ee and conversion for pharmaceutical intermediates.
Patent CN109020872B details a novel method converting unwanted paroxetine isomers into valuable racemic intermediates, offering significant cost reduction and supply chain efficiency for pharmaceutical manufacturers.
Novel patent CN106749116B details efficient synthesis of 3-aminomethyl tetrahydrofuran offering high purity and scalable production for global pharmaceutical intermediate supply chains.
Patent CN106854200B reveals high-purity Ceritinib synthesis. Optimized catalytic route ensures supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN116023271B details a high-yield p-fluoroaniline synthesis using Ni-Ag catalysts, offering significant cost reduction and supply reliability for pharmaceutical intermediate manufacturing.